Silvaco Group, Inc.
For the period ended Dec 31, 2025. Filed Mar 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 12, 2026
SVCO$7.45+2.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
(in thousands)
| Year Ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net loss | $(41,206) | $(39,404) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 3,470 | 1,285 |
| Stock-based compensation expense | 10,813 | 26,915 |
| Loss on fixed asset disposal | 38 | — |
| Provision for credit losses | (80) | 351 |
| Accretion of discount on marketable securities, net | (490) | (1,685) |
| Litigation settlement | 13,069 | 11,306 |
| Loss on debt extinguishment | — | 718 |
| Change in fair value of contingent consideration | 94 | (27) |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 2,288 | (5,971) |
| Contract assets | (2,667) | (10,293) |
| Prepaid expense and other current assets | (164) | (790) |
| Other assets | 1,281 | 57 |
| Accounts payable | (781) | 1,326 |
| Accrued expenses and other current liabilities | (27,626) | (2,160) |
| Related party funding of litigation settlement | 8,125 | — |
| Accrued income taxes | 817 | 74 |
| Deferred revenue | 1,508 | (1,585) |
| Other non-current liabilities | (2,395) | 109 |
| Net cash used in operating activities | (33,906) | (19,774) |
| Cash flows from investing activities: | ||
| Purchases of marketable securities | — | (99,630) |
| Sales of marketable securities | 32,288 | — |
| Maturities of marketable securities | 34,900 | 33,600 |
| Proceeds from fixed asset disposal | 32 | — |
| Purchases of property and equipment | (618) | (505) |
| Acquisition of businesses | (32,879) | — |
| Net cash provided by (used in) investing activities | 33,723 | (66,535) |
| Cash flows from financing activities: | ||
| Proceeds from initial public offering, net of underwriting fees | — | 106,020 |
| Proceeds from issuance of convertible note, net of debt issuance costs | — | 4,852 |
| Proceeds from loan facility | — | 4,250 |
| Repayment of loan facility | — | (4,250) |
| Repayment of related party line of credit | — | (2,000) |
| Proceeds from issuance of common stock for share-based awards | 899 | 315 |
| Payroll taxes related to shares withheld from employees | (1,808) | (4,575) |
| Deferred transaction costs | — | (2,649) |
| Contingent consideration | (46) | (74) |
| Payments of vendor financing obligation | (1,259) | (588) |
| Net cash (used in) provided by financing activities | (2,214) | 101,301 |
| Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash | 49 | 193 |
| Net (decrease) increase in cash and cash equivalents | (2,348) | 15,185 |
| Cash, cash equivalents and restricted cash, beginning of period | 19,606 | 4,421 |
| Cash, cash equivalents and restricted cash, end of period | $17,258 | $19,606 |
| Cash, cash equivalents and restricted cash: | ||
| Cash and cash equivalents | 9,008 | 19,606 |
| Restricted cash | 8,250 | — |
| Total cash, cash equivalents and restricted cash | $17,258 | $19,606 |
| Supplemental disclosures of cash flow information: | ||
| Income taxes paid | $550 | $625 |
| Interest paid | $359 | $498 |
| Noncash investing and financing activities: | ||
| Right of use assets obtained in exchange for lease obligations | $2,400 | $607 |
| Fair value of common stock issued in acquisition of businesses | $5,267 | $— |
| Issuance of equity upon Micron Note conversion | $— | $5,589 |
| Financial obligation incurred upon purchase of NXP IP | $— | $4,979 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.